Study to evaluate the effect of efavirenz coadministration on the pharmacokinetics of the active moieties of a combined oral contraceptive containing ethinyl estradiol and norgestimate [ethinylestradiol/norgestimate] in healthy female subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2011
At a glance
- Drugs Efavirenz; Ethinylestradiol/norgestimate
- Indications HIV infections; Pregnancy
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 02 Nov 2007 Status changed from in progress to completed.
- 15 Jun 2007 Status changed from recruiting to in progress.
- 24 Dec 2006 Status change